Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Telomerase prolongs the lifespan of normal human ovarian surface epithelial cells without inducing neoplastic phenotype.

Alvero AB, Fishman DA, Qumsiyeh MB, Garg M, Kacinski BM, Sapi E.

J Soc Gynecol Investig. 2004 Dec;11(8):553-61.

PMID:
15582501
2.

Apoptosis-based evaluation of chemosensitivity in ovarian cancer patients.

Flick MB, O'Malley D, Rutherford T, Rodov S, Kamsteeg M, Hao XY, Schwartz P, Kacinski BM, Mor G.

J Soc Gynecol Investig. 2004 May;11(4):252-9.

PMID:
15120700
3.
4.

cDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer model.

Kluger HM, Kluger Y, Gilmore-Hebert M, DiVito K, Chang JT, Rodov S, Mironenko O, Kacinski BM, Perkins AS, Sapi E.

Lab Invest. 2004 Mar;84(3):320-31.

5.

Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis.

Kluger HM, Dolled-Filhart M, Rodov S, Kacinski BM, Camp RL, Rimm DL.

Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):173-7.

6.

Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression.

Ide H, Seligson DB, Memarzadeh S, Xin L, Horvath S, Dubey P, Flick MB, Kacinski BM, Palotie A, Witte ON.

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14404-9. Epub 2002 Oct 15.

7.

Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group.

Jones GW, Kacinski BM, Wilson LD, Willemze R, Spittle M, Hohenberg G, Handl-Zeller L, Trautinger F, Knobler R.

J Am Acad Dermatol. 2002 Sep;47(3):364-70.

PMID:
12196745
8.

Regulation of Fas ligand expression by estrogen in normal ovary.

Sapi E, Brown WD, Aschkenazi S, Lim C, Munoz A, Kacinski BM, Rutherford T, Mor G.

J Soc Gynecol Investig. 2002 Jul-Aug;9(4):243-50.

PMID:
12113885
9.
10.

Apoptosis and cutaneous T cell lymphoma.

Kacinski BM, Flick M.

Ann N Y Acad Sci. 2001 Sep;941:194-9. Review.

PMID:
11594573
11.

RU-486 can abolish glucocorticoid-induced increases in CSF-1 receptor expression in primary human breast carcinoma specimens.

Kacinski BM, Flick MB, Sapi E.

J Soc Gynecol Investig. 2001 Mar-Apr;8(2):114-6.

PMID:
11336883
12.

Serum levels of macrophage colony-stimulating factor in trophoblastic disease.

Kohorn EI, Kacinski BM, Stanley ER.

Gynecol Oncol. 2001 Mar;80(3):383-6.

PMID:
11263936
13.

The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma.

Toy EP, Chambers JT, Kacinski BM, Flick MB, Chambers SK.

Gynecol Oncol. 2001 Feb;80(2):194-200.

PMID:
11161859
14.

Evaluation of T-cell receptor gene rearrangements in patients with recurrent patch/plaque (T2) CTCL (mycosis fungoides).

Thayu M, Tallini G, Glusac EJ, Kacinski BM, Wilson LD.

Yale J Biol Med. 1999 Nov-Dec;72(6):365-75.

15.

Roles of Fas and Fas ligand during mammary gland remodeling.

Song J, Sapi E, Brown W, Nilsen J, Tartaro K, Kacinski BM, Craft J, Naftolin F, Mor G.

J Clin Invest. 2000 Nov;106(10):1209-20.

16.

Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva.

Han SC, Kim DH, Higgins SA, Carcangiu ML, Kacinski BM.

Int J Radiat Oncol Biol Phys. 2000 Jul 15;47(5):1235-44.

PMID:
10889377
17.

Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides.

Wilson LD, Jones GW, Kim D, Rosenthal D, Christensen IR, Edelson RL, Heald PW, Kacinski BM.

J Am Acad Dermatol. 2000 Jul;43(1 Pt 1):54-60.

PMID:
10863224
19.

Signal transduction pathways regulated by CSF-1 receptors modulate the in vitro radiosensitivity of mammary epithelial cells.

Kacinski BM, Rodov S, Sapi E.

Int J Radiat Oncol Biol Phys. 1999 Nov 1;45(4):969-73.

PMID:
10571204
20.

Characterization of type I collagen synthesis and maturation in uterine carcinosarcomas.

Kauppila S, Stenbäck F, Kacinski BM, Carcangiu ML, Risteli J, Risteli L.

Cancer. 1999 Oct 1;86(7):1299-306.

PMID:
10506717
21.

The role of CSF-1 in normal and neoplastic breast physiology.

Sapi E, Kacinski BM.

Proc Soc Exp Biol Med. 1999 Jan;220(1):1-8. Review.

PMID:
9893162
22.

Prognostic significance of colony-stimulating factor receptor expression in ipsilateral breast cancer recurrence.

Maher MG, Sapi E, Turner B, Gumbs A, Perrotta PL, Carter D, Kacinski BM, Haffty BG.

Clin Cancer Res. 1998 Aug;4(8):1851-6.

23.

Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancer.

Santala M, Risteli J, Risteli L, Puistola U, Kacinski BM, Stanley ER, Kauppila A.

Br J Cancer. 1998 Jun;77(11):1825-31.

24.

Long CAG/CTG repeats in mice.

King BL, Sirugo G, Nadeau JH, Hudson TJ, Kidd KK, Kacinski BM, Schalling M.

Mamm Genome. 1998 May;9(5):392-3. No abstract available.

PMID:
9545500
25.

Expression of CSF-I and CSF-I receptor by normal lactating mammary epithelial cells.

Sapi E, Flick MB, Rodov S, Carter D, Kacinski BM.

J Soc Gynecol Investig. 1998 Mar-Apr;5(2):94-101.

PMID:
9509388
27.

Local superficial radiotherapy in the management of minimal stage IA cutaneous T-cell lymphoma (Mycosis Fungoides).

Wilson LD, Kacinski BM, Jones GW.

Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):109-15.

PMID:
9422565
28.

Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.

Turner BC, Knisely JP, Kacinski BM, Haffty BG, Gumbs AA, Roberts KB, Frank AH, Peschel RE, Rutherford TJ, Edraki B, Kohorn EI, Chambers SK, Schwartz PE, Wilson LD.

Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):77-84.

PMID:
9422561
29.

Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides).

Quirós PA, Jones GW, Kacinski BM, Braverman IM, Heald PW, Edelson RL, Wilson LD.

Int J Radiat Oncol Biol Phys. 1997 Jul 15;38(5):1027-35.

PMID:
9276369
31.

Recognition of activated CSF-1 receptor in breast carcinomas by a tyrosine 723 phosphospecific antibody.

Flick MB, Sapi E, Perrotta PL, Maher MG, Halaban R, Carter D, Kacinski BM.

Oncogene. 1997 May 29;14(21):2553-61.

32.

Repeat expansion detection analysis of (CAG)n tracts in tumor cell lines, testicular tumors, and testicular cancer families.

King BL, Peng HQ, Goss P, Huan S, Bronson D, Kacinski BM, Hogg D.

Cancer Res. 1997 Jan 15;57(2):209-14.

33.
34.

Independent regulation of invasion and anchorage-independent growth by different autophosphorylation sites of the macrophage colony-stimulating factor 1 receptor.

Sapi E, Flick MB, Rodov S, Gilmore-Hebert M, Kelley M, Rockwell S, Kacinski BM.

Cancer Res. 1996 Dec 15;56(24):5704-12.

35.

Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphoma.

Wilson LD, Quiros PA, Kolenik SA, Heald PW, Braverman IM, Edelson RL, Kacinski BM.

J Am Acad Dermatol. 1996 Jul;35(1):69-73.

PMID:
8682967
37.

Microsatellite instability in ovarian neoplasms.

King BL, Carcangiu ML, Carter D, Kiechle M, Pfisterer J, Pfleiderer A, Kacinski BM.

Br J Cancer. 1995 Aug;72(2):376-82.

38.

Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy.

Wilson LD, Licata AL, Braverman IM, Edelson RL, Heald PW, Feldman AM, Kacinski BM.

Int J Radiat Oncol Biol Phys. 1995 Jul 15;32(4):987-95.

PMID:
7607973
39.

Macrophage colony-stimulating factor 1, a clinically useful tumor marker in endometrial adenocarcinoma: comparison with CA 125 and the aminoterminal propeptide of type III procollagen.

Hakala A, Kacinski BM, Stanley ER, Kohorn EI, Puistola U, Risteli J, Risteli L, Tomás C, Kauppila A.

Am J Obstet Gynecol. 1995 Jul;173(1):112-9.

PMID:
7631667
40.
41.

Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase.

Chambers SK, Wang Y, Gertz RE, Kacinski BM.

Cancer Res. 1995 Apr 1;55(7):1578-85.

42.
43.

Co-cultivation of ovarian carcinoma cells with dermal fibroblasts induces fibroblast expression of sex steroid receptor transcripts and protein.

Kommoss F, Kiechle-Schwarz M, Dubois A, Pfisterer J, Spinner D, Madjar H, Bauknecht T, Pfleiderer A, Kacinski BM.

Int J Gynecol Cancer. 1995 Mar;5(2):101-106.

PMID:
11578462
44.

Transcriptional regulation of the c-fms (CSF-1R) proto-oncogene in human breast carcinoma cells by glucocorticoids.

Sapi E, Flick MB, Gilmore-Hebert M, Rodov S, Kacinski BM.

Oncogene. 1995 Feb 2;10(3):529-42.

PMID:
7845678
45.

CSF-1 and its receptor in ovarian, endometrial and breast cancer.

Kacinski BM.

Ann Med. 1995 Feb;27(1):79-85. Review.

PMID:
7742005
46.

Expression of neu antigen in normal lactating and prepartum mammary epithelial cells.

Kacinski BM, Nguyen J, Carter D.

J Soc Gynecol Investig. 1995 Jan-Feb;2(1):51-6.

PMID:
9420849
47.

Tumor-stromal cytokine interactions in ovarian neoplasms.

Kacinski BM.

EXS. 1995;74:181-90. Review. No abstract available.

PMID:
8527894
48.

Messenger RNA decay of macrophage colony-stimulating factor in human ovarian carcinomas in vitro.

Chambers SK, Kacinski BM.

J Soc Gynecol Investig. 1994 Oct-Dec;1(4):310-6.

PMID:
9419789
49.

Co-expression of M-CSF transcripts and protein, FMS (M-CSF receptor) transcripts and protein, and steroid receptor content in adenocarcinomas of the ovary.

Kommoss F, Wölfle J, Bauknecht T, Pfisterer J, Kiechle-Schwarz M, Pfleiderer A, Sauerbrei W, Kiehl R, Kacinski BM.

J Pathol. 1994 Oct;174(2):111-9.

PMID:
7965406
50.

Supplemental Content

Loading ...
Support Center